EYENOVIA

EYEN NASDAQ
3.110
-0.210
-6.33%
休市 16:00 08/16 EDT
开盘
3.280
昨收
3.320
最高
3.280
最低
3.090
成交量
5.30万
成交均量(3M)
11.40万
52周最高
6.98
52周最低
2.400
换手率
0.31%
市值
5,318.33万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供EYENOVIA EYEN股票价格,EYENOVIA股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Eyenovia, Inc. is a clinical stage biopharmaceutical company. The Company is engaged in developing a pipeline of micro-doses therapeutics products utilizing the patented piezo-print delivery technology. Eyenovia’s pipeline is focused on the late-stage development of microdosed medications for mydriasis, myopia progression, glaucoma, and other eye diseases. MicroStat is a combination micro-formulation product (phenylephrine-tropicamide) candidate for pharmacologic mydriasis (eye dilation). MicroPine is topical treatment for progressive myopia, a back-of-the-eye disease. MicroProst is latanoprost formulation product candidate, which is being developed for the reduction of IOP in patients with Chronic Angle Closure Glaucoma (CACG), as well as Primary Open Angle Glaucoma (POAG) and Ocular Hypertension. MicroTears is a micro-droplet ocular hyperemia (red eye), pruritis (itch) and ocular lubrication product.
展开 >

最近浏览

名称
价格
涨跌幅